NVCR insider trading
NasdaqGS HealthcareNovoCure Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About NovoCure Ltd
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Company website: www.novocure.com
NVCR insider activity at a glance
FilingIQ has scored 1,470 insider transactions for NVCR since Oct 2, 2015. The most recent filing in our index is dated Apr 28, 2026.
Across the full history, 9 open-market purchases
and 866 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NVCR insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NVCR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading NVCR
Frequently asked
- How many insider trades does FilingIQ track for NVCR?
- FilingIQ tracks 1,470 Form 4 insider transactions for NVCR (NovoCure Ltd), covering filings from Oct 2, 2015 onwards. 44 of those were filed in the last 90 days.
- Are NVCR insiders net buyers or net sellers?
- Across the full Form 4 history for NVCR, 9 transactions (1%) were open-market purchases and 866 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NVCR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is NVCR in?
- NovoCure Ltd (NVCR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.23B.
Methodology & sources
Every NVCR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.